Factor V Leiden paradox: risk of deepvein thrombosis but not of pulmonary embolism
- 15 July 2000
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 356 (9225) , 182-183
- https://doi.org/10.1016/s0140-6736(00)02476-4
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolismBritish Journal of Haematology, 2000
- Blood coagulationThe Lancet, 2000
- Increased Tissue Factor-initiated Prothrombin Activation as a Result of the Arg506 → Gln Mutation in Factor VLEIDENPublished by Elsevier ,1997
- An Antifibrinolytic Mechanism Describing the Prothrombotic Effect Associated with Factor VLeidenPublished by Elsevier ,1996
- Resistance to activated protein C in an unselected population of patients with pulmonary embolismThe Lancet, 1996
- Arachidonate and Related Unsaturated Fatty Acids Selectively Inactivate the Guanine Nucleotide-binding Regulatory Protein, GzαPublished by Elsevier ,1996
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993